Publications

Sort by: Date | Author | Title

Haslund-Krog, S. S., Jorgensen, I. M., Henriksen, T. B., Dalhoff, K., Debes, N. M., van den Anker, J. & Holst, H. (2021). Challenges in conducting paediatric trials with off-patent drugs. Contemporary Clinical Trials Communications, 23, Article 100783. https://doi.org/10.1016/j.conctc.2021.100783
Hatje, F., Wedekind, U., Sachs, W., Loreth, D., Reichelt, J., Demir, F., Kosub, C., Heintz, L., Tomas, N., Huber, T., Skuza, S., Sachs, M., Zielinski, S., Rinschen, M. & Meyer-Schwesinger, C. (2021). Tripartite Separation of Glomerular Cell-Types and Proteomes From Reporter-Free Mice. Journal of the American Society of Nephrology : JASN, 32(9), 2175-2193. https://doi.org/10.1681/ASN.2020091346
Havdahl, A., Niarchou, M., Starnawska, A., Uddin, M., Van Der Merwe, C. & Warrier, V. (2021). Genetic contributions to autism spectrum disorder. Psychological Medicine, 51(13), 2260-2273. https://doi.org/10.1017/S0033291721000192
Helgestad, O. K. L., Povlsen, A. L., Josiassen, J., Möller, S., Hassager, C., Jensen, L. O., Holmvang, L., Schmidt, H., Moller, J. E. & Ravn, H. B. (2021). Data-driven point-of-care risk model in patients with acute myocardial infarction and cardiogenic shock. European Heart Journal: Acute Cardiovascular Care, 10(6), 668-675. https://doi.org/10.1093/ehjacc/zuab045
Henning, M. A. S., Ibler, K. S., Loft, I., Ullum, H., Erikstrup, C., Nielsen, K. R., Topholm Bruun, M., Hjalgrim, H., Sørensen, E., Burgdorf, K. S., Mikkelsen, S., Hansen, T. F., Pedersen, O. B. & Jemec, G. B. E. (2021). Epidemiology of Hyperhidrosis in Danish Blood Donors. Acta Dermato-Venereologica, 101(4), Article adv00345. https://doi.org/10.2340/00015555-3790
Herlin, L. K., Hansen, K. S., Bodilsen, J., Larsen, L., Brandt, C. T., Andersen, C. Ø., Hansen, B. R., von Lüttichau, H. R., Helweg-Larsen, J., Wiese, L., Storgaard, M., Nielsen, H. & Mogensen, T. (2021). Varicella Zoster Virus Encephalitis in Denmark From 2015 to 2019: A Nationwide Prospective Cohort Study. Clinical Infectious Diseases, 72(7), 1192–1199. https://doi.org/10.1093/cid/ciaa185
Hess, J. L., Tylee, D. S., Mattheisen, M., Schizophrenia Working Group of the Psychiatric Genomics Consortium, Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Børglum, A. D., Als, T. D., Grove, J., Werge, T., Mortensen, P. B., Mors, O., Nordentoft, M., Hougaard, D. M., Byberg-Grauholm, J., Bækvad-Hansen, M., Greenwood, T. A., Tsuang, M. T., Curtis, D., Steinberg, S. ... Glatt, S. J. (2021). A polygenic resilience score moderates the genetic risk for schizophrenia. Molecular Psychiatry, 26(3), 800–815. https://doi.org/10.1038/s41380-019-0463-8
Hoffmann, M., Hofmann-Winkler, H., Smith, J. C., Krüger, N., Arora, P., Sørensen, L. K., Søgaard, O. S., Hasselstrøm, J. B., Winkler, M., Hempel, T., Raich, L., Olsson, S., Danov, O., Jonigk, D., Yamazoe, T., Yamatsuta, K., Mizuno, H., Ludwig, S., Noé, F. ... Pöhlmann, S. (2021). Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine, 65, Article 103255. https://doi.org/10.1016/j.ebiom.2021.103255